Evidence map›Paper›PMID 32923662›Full record

ArticleCannabis and cannabinoid research2020

Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain Complaints.

Susanna A Curtis, Amanda M Brandow, Michelle DeVeaux, Daniel Zeltermam, Lesley Devine, John D Roberts

Open access · bronzeAbstract read
In one paragraph

Article in Cannabis and cannabinoid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Chronic pain in the aging adult with sickle cell disease.Frontiers in pain research (Lausanne, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Pain in sickle cell disease: current and potential translational therapies.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Susanna A CurtisDepartment of Internal Medicine, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Amanda M BrandowDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Michelle DeVeauxDepartment of Early Clinical Development, Regeneron Pharmaceuticals, Tarrytown, New York.
Daniel ZeltermamDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut.
Lesley DevineDepartment of Internal Medicine, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
John D RobertsDepartment of Internal Medicine, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Yale Cancer Center · USMedical College of Wisconsin · USRegeneron (United States) · USYale University · US

Funding

Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
NHLBI NIH HHS T32 HL007974NIDDK NIH HHS U54 DK106857
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cannabinoidcannabispainsickle cell disease

Identifiers

PMID32923662
PMCPMC7480712
OpenAlexW3006071673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.